Navigation Links
Abacus International Expands Annual Partnership With HealthEconomics.Com

Ponte Vedra Beach, Florida (PRWEB) March 08, 2013

HealthEconomics.Com is pleased to announce their continuing partnership with Abacus International, specialists in health economics, systematic review, and HTA.

"We're excited that Abacus has chosen not only to come aboard for a fourth year, but to expand their access to the variety of services we offer by upgrading their membership in our Annual Marketing Partnership Program,” said Dr. Patti Peeples, President of HealthEconomics.Com. “Abacus International is regarded throughout the pharmaceutical and biotech industry for their strategic consulting in health economic and evidence-based solutions for all phases of the product life cycle. Their post-launch communication tools for presenting cost and outcomes data for various customer groups is particularly well-regarded. It's an honor to know a key provider such as Abacus views HealthEconomics.Com as an important resource in promoting their ever-evolving range of services."

The HealthEconomics.Com Annual Marketing Partnership Program allows partners to communicate with a global community of 20,000 pharmaceutical, health outcomes research, pricing and reimbursement professionals by offering a tested array of digital marketing solutions. To date, 26 Annual Marketing Partners have signed with HealthEconomics.Com with >90%, like Abacus International, renewing their partnerships every year.

Founded in 1995, Abacus International ( develops evidence-based market access solutions for many of the world's leading healthcare companies. Key services such as strategic payer landscaping, health economics and modeling, and value communication tools provide integrated market access solutions throughout the product life-cycle of a pharmaceutical or medical device. With a reputation built on a commitment to academic rigor and keen market insight, Abacus International continues to exceed client expectations with intelligent solutions that insure the product development process, from pre-launch to market access, achieves the best possible outcome.

In December 2012 Abacus International was acquired by Decision Resources Group, one of the world’s leading research and advisory firms focusing on healthcare insights and analysis.

HealthEconomics.Com ( is the world’s most comprehensive and credible website for resources in healthcare value and market access and is a trusted resource for the biopharmaceutical and healthcare industry. HealthEconomics.Com, established in 1994, also provides policy updates, professional development, education resources, jobs and conferences for health economics, outcomes research, and reimbursement professionals. The website attracts over 10,000 visitors every month and the well-respected HealthEconomics.Com Newsletter reaches 20,000 professionals every week.

News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Manchester leads new international study investigating Inflammatory Bowl Disease
2. Pediatric cancer charities partner to fund international collaborative research
3. Supply Chain Solutions + Business Intelligence = International Expansion for Scott Sheldon
4. Aerovox Announces Appointment of Marco Castillo to International Sales Manager
5. Global Food Protection Institute Attends International Conference on Food Safety
6. International Conference on Governance of Tobacco in the 21st Century
7. Columbus Center for Women’s Health Research is participating in an International Study for a New “Use-as-Needed” Treatment for Women with Sexual Dysfunction
8. International space station plays host to innovative infectious disease research
9. Joan W. Miller, M.D., F.A.R.V.O., elected to Academia Ophthalmologica Internationalis
10. International study suggests improved treatment alternative for lymphoid leukemia
11. 15th International Celiac Disease Symposium will unveil new research, dispel gluten-free myths
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: